Sodium-Glucose Cotransporter-2 Inhibitor-Associated Euglycemic Diabetic Ketoacidosis After Orthotopic Heart Transplant in a Prediabetic Patient: A Case Report.
Sign Up to like & getrecommendations! Published in 2021 at "Transplantation proceedings"
DOI: 10.1016/j.transproceed.2021.08.017
Abstract: Postoperative euglycemic diabetic ketoacidosis (euDKA) associated with sodium-glucose cotransporter-2 (SGLT2) inhibitor use has been well-documented and carries a Food and Drug Administration recommendation to hold SGLT2 inhibitors 3 to 4 days before a planned surgical… read more here.
Keywords: inhibitor; sodium glucose; heart; euglycemic diabetic ... See more keywords
Euglycemic diabetic ketoacidosis caused by dapagliflozin
Sign Up to like & getrecommendations! Published in 2018 at "Medicine"
DOI: 10.1097/md.0000000000011056
Abstract: Rationale: Diabetic ketoacidosis is a serious and potentially life-threatening acute complication of diabetes mellitus (DM). Euglycemic diabetic ketoacidosis (eDKA) is however challenging to identify in the emergency department (ED) due to absence of marked hyperglycemia,… read more here.
Keywords: ketoacidosis; euglycemic diabetic; blood; dapagliflozin ... See more keywords
Intraoperative Diagnosis of Sodium-Glucose Cotransporter 2 Inhibitor-Associated Euglycemic Diabetic Ketoacidosis: A Case Report.
Sign Up to like & getrecommendations! Published in 2021 at "A&A Practice"
DOI: 10.1213/xaa.0000000000001380
Abstract: The use of sodium-glucose cotransporter 2 (SGLT2) inhibitors is increasingly common in type 2 diabetes mellitus (DM) management. Patients taking an SGLT2 inhibitor are at risk for euglycemic diabetic ketoacidosis (EDKA). We report an intraoperative… read more here.
Keywords: intraoperative diagnosis; sodium glucose; glucose cotransporter; diabetic ketoacidosis ... See more keywords
Two Cases of Thyrotoxicosis and Euglycemic Diabetic Ketoacidosis Under Sodium-glucose Transport Protein 2 Inhibitor Treatment
Sign Up to like & getrecommendations! Published in 2022 at "Internal Medicine"
DOI: 10.2169/internalmedicine.8830-21
Abstract: Thyrotoxicosis and sodium-glucose transport protein 2 inhibitors (SGLT2is) are associated with the induction of euglycemic diabetic ketoacidosis (euDKA). We herein report two cases of euDKA in patients with diabetes mellitus wherein both thyrotoxicosis and SGLT2i… read more here.
Keywords: transport protein; glucose transport; euglycemic diabetic; diabetic ketoacidosis ... See more keywords
Euglycemic Diabetic Ketoacidosis Associated with Empagliflozin Use in the Course of the SARS-Cov-2 Pandemic.
Sign Up to like & getrecommendations! Published in 2020 at "Journal of the College of Physicians and Surgeons--Pakistan : JCPSP"
DOI: 10.29271/jcpsp.2020.10.110
Abstract: Sodium glucose cotransporter 2 (SGLT2) inhibitors are among the new generation oral anti-diabetic drugs that have started to be used in the treatment of type 2 diabetes mellitus. Although these drugs are highly beneficial, life-threatening… read more here.
Keywords: euglycemic diabetic; course; empagliflozin use; diabetic ketoacidosis ... See more keywords
Euglycemic Diabetic Ketoacidosis Associated With SGLT2 Inhibitor Therapy: A Case Report.
Sign Up to like & getrecommendations! Published in 2023 at "AACN advanced critical care"
DOI: 10.4037/aacnacc2023830
Abstract: Sodium-glucose cotransporter-2 inhibitors are now considered second-line treatment agents for type 2 diabetes and offer a unique treatment approach with added cardiorenal benefits. Drugs in this class increase the risk of euglycemic diabetic ketoacidosis, which… read more here.
Keywords: ketoacidosis associated; euglycemic diabetic; inhibitor; case ... See more keywords
Dietary Changes Leading to Euglycemic Diabetic Ketoacidosis in Sodium-Glucose Cotransporter-2 Inhibitor Users: A Challenge for Primary Care Physicians?
Sign Up to like & getrecommendations! Published in 2022 at "Korean Journal of Family Medicine"
DOI: 10.4082/kjfm.22.0003
Abstract: Background The use of euglycemic diabetic ketoacidosis (EDKA) related to sodium-glucose cotransporter 2 inhibitors (SGLT2i) use in people with diabetes has been increasingly reported. The causes are multifactorial, and dietary changes in SGLT2i users were… read more here.
Keywords: edka; euglycemic diabetic; dietary changes; diabetic ketoacidosis ... See more keywords
Euglycemic diabetic ketoacidosis: A missed diagnosis
Sign Up to like & getrecommendations! Published in 2021 at "World Journal of Diabetes"
DOI: 10.4239/wjd.v12.i5.514
Abstract: Euglycemic diabetic ketoacidosis (DKA) is an acute life-threatening metabolic emergency characterized by ketoacidosis and relatively lower blood glucose (less than 11 mmol/L). The absence of hyperglycemia is a conundrum for physicians in the emergency department… read more here.
Keywords: insulin; ketoacidosis; diagnosis; euglycemic diabetic ... See more keywords
Sodium-glucose co-transporter 2 inhibitors induced euglycemic diabetic ketoacidosis within four days of initiation
Sign Up to like & getrecommendations! Published in 2022 at "World Journal of Diabetes"
DOI: 10.4239/wjd.v13.i3.272
Abstract: Euglycemic diabetic ketoacidosis (EDKA) is a well-known complication of sodium-glucose co-transporter 2 inhibitors, and many cases with variable onset following the initiation of these agents are reported before, with a median onset of approximately 2… read more here.
Keywords: euglycemic diabetic; glucose transporter; transporter inhibitors; diabetic ketoacidosis ... See more keywords